Search results
AbbVie Stock Poised for New All-Time Highs in 2024 | Investing.com
Investing.com· 2 days agoAbbVie had a better-than-expected quarter and guided higher; the post-release price drop is a dip...
3 Reasons to Buy AbbVie Stock on the Dip
Motley Fool via Yahoo Finance· 4 days agoIt's been more than a year since AbbVie (NYSE: ABBV) lost patent exclusivity for its most important product, Humira, an immunology medicine. Though this...
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoAbbVie's acquisition of ImmunoGen strengthens its oncology pipeline and solid tumor capabilities. Robust financial performance with $12.3 billion in net...
Michael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks By Investing.com
Investing.com· 6 days agoMichael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks
Keating trades AbbVie, Goldman Sachs, and Lowe's notes in IRA By Investing.com
Investing.com· 6 days agoIn recent financial activities, Massachusetts 9th congressional district Representative William R....
Analyst Report: Royalty Pharma plc
Morningstar Research via Yahoo Finance· 5 hours agoThe firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including ...
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 8 hours agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
AbbVie to Present at the Bank of America Securities Healthcare Conference
FOX 4 Kansas City· 4 days agoReents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., senior vice president, chief medical ...
Health officials warn Californians of risks of fake Botox. Here's what to look for
Los Angeles Times· 9 hours agoFake versions of Botox have popped up in California, raising alarm among public health officials who...
Keeping an Eye on Abbvie Inc
Knox Daily· 3 days agoAbbvie Inc’s recently made public that its EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas unloaded Company’s shares for reported $3.72 million on Mar 20 ’24. In the deal valued ...
